Delivery Order SPE2DB24D2018-SPE2DB25FWWX2
Award Date 9/19/25
Potential Completion Date 9/22/25
Potential Value $10K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of XELJANZ XR 11 mg tablets in quantities of 30 units. This firm fixed price delivery order, valued at $8,141.67, represents a non-competitive set-aside procurement and is scheduled for ultimate completion by August 1, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of XELJANZ XR 11 mg tablets in quantities of 30 units. This is a firm fixed price delivery order valued at $25,624.50, with performance completion scheduled for September 15, 2025. The work will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This award was not designated as a set-aside contract and represents a competitively...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of XELJANZ XR 11 mg tablets in quantities of 30 units. This firm fixed-price delivery order, valued at $15,662.64, represents a competitively awarded contract with no set-aside designation and is scheduled for completion by July 25, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of XELJANZ XR 11 mg tablets in a quantity of 30 units, valued at $8,055.93. This is a firm fixed price delivery order with no set-aside designation, indicating the award was made through open competition. The order is scheduled for completion by September 16, 2025, and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania location. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 15, 2025, for the supply of XELJANZ XR 11 mg tablets in a quantity of 30 units, valued at $29,798.59. This is a firm fixed-price delivery order issued without a set-aside designation, indicating it was competitively awarded. The contract is set to be completed by July 16, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of XELJANZ XR 11 mg tablets in quantities of 30 tablets per unit. This non-set-aside, competitively awarded contract carries a ceiling value of $15,769.68 and is priced on a firm fixed-price basis, with an ultimate completion date of September 12, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $38,053.59 on September 11, 2025, for the supply of XELJANZ XR 11 mg tablets in quantities of 30s. This is a firm fixed-price delivery order with no set-aside designation, representing a competitive award under the company's existing contract vehicle with DLA. The pharmaceutical products will be delivered to the place of performance in Conshohocken, Pennsylvania, with an ultimate completion date of September...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for supply of XELJANZ XR 11 mg tablets in quantities of 30 units, with a contract ceiling value of $4,095.71. This is a firm fixed price delivery order with no set-aside designation, competitively awarded through open competition. The order is scheduled for completion by September 10, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of XELJANZ XR 11 mg tablets (30-count units) with a contract value of $7,678.32 and a firm fixed price structure. This non-set-aside competitive award is part of a larger Indefinite Delivery Contract (IDC) vehicle—the DLA Troop Support Medical SPE2DX contract valued at $999,999,999.00 and extending through December 2026—which serves as a comprehensive global pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of XELJANZ XR 11 mg tablets in quantities of 30 units. This $9,372.07 firm fixed-price delivery order represents a non-set-aside competitive award and is scheduled for completion by August 28, 2025. The contract is executed under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion vehicle running through December...